Long-term treatment of residual or recurrent low-grade endometrial stromal sarcoma with aromatase inhibitors: A report of two cases and a review of the literature

Oncology Letters

Volumn 10, Issue 5, 2015, Pages 3310-3314

  Ryu, Hyewon ^a   Choi, Yoon Seok ^a   Song, Ik Chan ^a   Yun, Hwan Jung ^a   Jo, Deog Yeon ^a   Kim, Samyong ^a   Lee, Hyo Jin ^a  

^a Chungnam National University College of Medicine   (South Korea)

Author keywords

Anastrozole; Aromatase inhibitor; Endometrial stromal sarcoma; Letrozole

Indexed keywords

ANASTROZOLE; ESTROGEN RECEPTOR; LETROZOLE; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CONTROL; DISEASE COURSE; DISEASE FREE SURVIVAL; ENDOMETRIUM SARCOMA; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84942424771     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3674     Document Type: Article

References (27)

1. Olah KS, Gee H, Blunt S, Dunn JA, Kelly K and Chan KK: Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer 27: 1095-1099, 1991.
2. Harlow BL, Weiss NS and Lofton S: The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 76: 399-402, 1986.
3. Evans HL: Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50: 2170-2182, 1982.
4. Amant F, Vergote I and Moerman P: The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned. Gynecol Oncol 95: 412-413, author reply 413, 2004.
5. Reich O and Regauer S: Survey of adjuvant hormone therapy in patients after endometrial stromal sarcoma. Eur J Gynaecol Oncol 27: 150-152, 2006.
6. Pink D, Lindner T, Mrozek A, Kretzschmar A, Thuss-Patience PC, Dörken B and Reichardt P: Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: Single center experience with 10 cases and review of the literature. Gynecol Oncol 101: 464-469, 2006.
7. Ashraf-Ganjoei T, Behtash N, Shariat M and Mosavi A: Low grade endometrial stromal sarcoma of uterine corpus, a clinico-pathological and survey study in 14 cases. World J Surg Oncol 4: 50, 2006.
8. Amant F, Moerman P, Cadron I, Neven P, Berteloot P and Vergote I: The diagnostic problem of endometrial stromal sarcoma: Report on six cases. Gynecol Oncol 90: 37-43, 2003.
9. Reich O and Regauer S: Hormonal therapy of endometrial stromal sarcoma. Curr Opin Oncol 19: 347-352, 2007.
10. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC and Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000.
11. Maluf FC, Sabbatini P, Schwartz L, Xia J and Aghajanian C: Endometrial stromal sarcoma: Objective response to letrozole. Gynecol Oncol 82: 384-388, 2001.
12. Spano JP, Soria JC, Kambouchner M, Piperno-Neuman S, Morin F, Morere JF, Martin A and Breau JL: Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol 20: 87-93, 2003.
13. Leunen M, Breugelmans M, De Sutter P, Bourgain C and Amy JJ: Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecol Oncol 95: 769-771, 2004.
14. Leiser AL, Hamid AM and Blanchard R: Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor. Gynecol Oncol 94: 567-571, 2004.
15. Brechot JM, Kamboucher M, Brauner M, Destable M, Duperron F and Morère JF: Pulmonary metastases from endometrial stromal sarcoma may benefit from hormone therapy. Rev Mal Respir 24: 69-72, 2007 (In French).
16. Landréat V, Paillocher N, Catala L, Foucher F, Descamps P and Levêque J: Low-grade endometrial stromal sarcoma of the uterus: Review of 10 cases. Anticancer Res 28: 2869-2874, 2008.
17. Krauss K, Bachmann C, Hartmann JT, Siegmann K, Sotlar K, Wallwiener D and Huober J: Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): Treatment with letrozole. Anticancer Res 27: 3477-3480, 2007.
18. Alkasi O, Meinhold-Heerlein I, Zaki R, Fasching P, Maass N, Jonat W and Beckmann MW: Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: A case report. Arch Gynecol Obstet 279: 57-60, 2009.
19. Tzakas E, Liu S, Todd RW and Redman CW: Hormonal therapy with letrozole prior to surgical management of recurrent metastatic low-grade endometrial stromal sarcoma (LGESS). J Obstet Gynaecol 29: 778-779, 2009.
20. Dahhan T, Fons G, Buist MR, Ten Kate FJ and van der Velden J: The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study. Eur J Obstet Gynecol Reprod Biol 144: 80-84, 2009.
21. Ioffe YJ, Li AJ, Walsh CS, Karlan BY, Leuchter R, Forscher C and Cass I: Hormone receptor expression in uterine sarcomas: Prognostic and therapeutic roles. Gynecol Oncol 115: 466-471, 2009.
22. Sylvestre VT and Dunton CJ: Treatment of recurrent endometrial stromal sarcoma with letrozole: A case report and literature review. Horm Cancer 1: 112-115, 2010.
23. Shoji K, Oda K, Nakagawa S, Kawana K, Yasugi T, Ikeda Y, Takazawa Y, Kozuma S and Taketani Y: Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: A case report. Med Oncol 28: 771-774, 2011.
24. Altman AD, Nelson GS, Chu P, Nation J and Ghatage P: Uterine sarcoma and aromatase inhibitors: Tom baker cancer centre experience and review of the literature. Int J Gynecol Cancer 22: 1006-1012, 2012.
25. Balleine RL, Earls PJ, Webster LR, Mote PA, deFazio A, Harnett PR and Clarke CL: Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma. Int J Gynecol Pathol 23: 138-144, 2004.
26. Chu MC, Mor G, Lim C, Zheng W, Parkash V and Schwartz PE: Low-grade endometrial stromal sarcoma: Hormonal aspects. Gynecol Oncol 90: 170-176, 2003.
27. Reich O, Regauer S, Urdl W, Lahousen M and Winter R: Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 82: 1030-1034, 2000.